搜索临床试验以:High-risk prostate cancer
总计87660个结果
-
Lawson Health Research Institute招聘中
-
Instituto do Cancer do Estado de São PauloJanssen, LP完全的
-
German Cancer Research CenterUniversity Hospital Freiburg; ABX CRO; Friedrich-Alexander-Universität Erlangen-Nürnberg完全的
-
Peking University Third HospitalBayer尚未招聘
-
Ning XuThe First Affiliated Hospital of Nanchang University; Zhongshan Hospital Xiamen University; Fujian... 和其他合作者尚未招聘前列腺癌 | 外科手术,未指定
-
Odense University HospitalZealand University Hospital; Rigshospitalet, Denmark; Sygehus Lillebaelt招聘中
-
Medical University of ViennaLund University; Ziekenhuis Netwerk Antwerpen (ZNA); St. Antonius Hospital; Azienda Ospedaliera... 和其他合作者尚未招聘前列腺癌 | 前列腺癌转移 | 寡转移 | 前列腺肿瘤 | 寡转移性疾病 | 前列腺癌骨转移
-
European Association of Urology Research FoundationNational Cancer Institute (NCI); UMC Utrecht; Erasmus Medical Center; University College Dublin; Vastra... 和其他合作者尚未招聘
-
University of Southern CaliforniaNational Cancer Institute (NCI)尚未招聘
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany尚未招聘
-
First Affiliated Hospital of Chongqing Medical...招聘中
-
Maastricht University Medical CenterJessa Hospital尚未招聘
-
Fusion Pharmaceuticals Inc.招聘中
-
Apollo Therapeutics Ltd尚未招聘大肠癌 | 胰腺癌 | 卵巢癌 | 前列腺癌 | 胃腺癌 | 胆管癌 | 三阴性乳腺癌 | 子宫内膜腺癌 | 阑尾腺癌
-
Oslo University HospitalUniversity Hospital, Akershus招聘中
-
Complement Theory Inc.招聘中
-
University College, LondonUniversity College London Hospitals招聘中
-
Adam S. Kibel, MDNational Cancer Institute (NCI)招聘中
-
858 Therapeutics, Inc.招聘中乳腺癌 | 胃癌 | 大肠癌 | 卵巢癌 | 前列腺癌 | 子宫内膜癌 | 上皮性卵巢癌 | BRCA1突变 | BRCA2突变 | 晚期或转移性实体瘤 | ER+乳腺癌 | 去势抵抗性前列腺癌 | BRCA突变美国
-
Qian QinJanssen, LP; UT Southwestern Comprehensive Cancer Center尚未招聘BRCA1基因突变 | BRCA2基因突变 | BRIP1基因突变 | PALB2基因突变 | CHEK2基因突变 | FANCA基因突变 | RAD51B基因突变 | RAD54L基因突变 | 转移性激素敏感性前列腺癌 (mHSPC) | 有害的 HRR 基因突变
-
Robert Bok, MD, PhDNational Cancer Institute (NCI)尚未招聘